Product Information
RECTASMOOTHE 5% CREAM is a generic product labeled by Leading Pharma, LLC, priced at $0.4361 per GM under NDC 69315030130. Its NADAC has been published 147 times since Feb 8, 2023.
Strength
5 g/100g
Manufacturer
Leading Pharma, LLCNDC
69315030130
Classification
Generic
Dosage Form
CREAM
Route
TOPICAL
Effective Date
11/19/2025
Active Ingredients
LIDOCAINEApproval Type
OTC Monograph
FDA Application
part346On Market Since
4/1/2011
Pharmacological Classes
Price Statistics
The NADAC for RECTASMOOTHE 5% CREAM has been published 147 times since Feb 8, 2023, and over the history we have for it it has risen 22.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.4361 per GM |
|---|---|
| All-time high | $0.4883 (Jul 16, 2025) |
| All-time low | $0.2633 (Jul 17, 2024) |
| 52-week high | $0.4655 |
| 52-week low | $0.4361 |
| Median price | $0.4250 |
| Average price | $0.4126 |
| Largest weekly change | +47.8% (May 17, 2023) |
| Weeks tracked | 147 |
| Tracking since | Feb 8, 2023 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
-3.2%
3Y
+4.1%
5Y
N/A
All
+22.1%
Last surveyed Nov 26, 2025 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Lidocaine 5% market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Leading Pharma, LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Lidocaine 5% market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Amide Local Anesthetic class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of RECTASMOOTHE 5% CREAM?
The current National Average Drug Acquisition Cost (NADAC) for RECTASMOOTHE 5% CREAM, manufactured by Leading Pharma, LLC, is $0.4361 per GM (NDC 69315030130), effective Nov 26, 2025.
How has the price of RECTASMOOTHE 5% CREAM changed over time?
Over the history we have for it, the NADAC for RECTASMOOTHE 5% CREAM has risen 22.1%. It has been tracked across 147 weekly CMS publications since Feb 8, 2023.
What are the highest and lowest recorded NADAC prices for RECTASMOOTHE 5% CREAM?
Since Feb 8, 2023, the NADAC for RECTASMOOTHE 5% CREAM has ranged from a low of $0.2633 (Jul 17, 2024) to a high of $0.4883 (Jul 16, 2025), with a median of $0.4250 per GM.
Are there cheaper alternatives to RECTASMOOTHE 5% CREAM?
No other NADAC-published product currently shares the active ingredient and strength of RECTASMOOTHE 5% CREAM in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures RECTASMOOTHE 5% CREAM?
RECTASMOOTHE 5% CREAM (NDC 69315030130) is labeled by Leading Pharma, LLC, and CMS classifies it as a generic product.